HK1121383A1 - Wound healing agent and composition - Google Patents

Wound healing agent and composition

Info

Publication number
HK1121383A1
HK1121383A1 HK09101299.7A HK09101299A HK1121383A1 HK 1121383 A1 HK1121383 A1 HK 1121383A1 HK 09101299 A HK09101299 A HK 09101299A HK 1121383 A1 HK1121383 A1 HK 1121383A1
Authority
HK
Hong Kong
Prior art keywords
composition
wound healing
healing agent
polypeptide
seq
Prior art date
Application number
HK09101299.7A
Other languages
English (en)
Inventor
Sylvie Colin
Salman Al-Mahmood
Original Assignee
Gene Signal Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/704,313 external-priority patent/US20080194478A1/en
Priority claimed from EP07290164A external-priority patent/EP1955704A1/en
Application filed by Gene Signal Int Sa filed Critical Gene Signal Int Sa
Publication of HK1121383A1 publication Critical patent/HK1121383A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK09101299.7A 2007-02-09 2009-02-11 Wound healing agent and composition HK1121383A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/704,313 US20080194478A1 (en) 2007-02-09 2007-02-09 Wound healing agent and composition
EP07290164A EP1955704A1 (en) 2007-02-09 2007-02-09 Wound healing agent and composition

Publications (1)

Publication Number Publication Date
HK1121383A1 true HK1121383A1 (en) 2009-04-24

Family

ID=39473279

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09101299.7A HK1121383A1 (en) 2007-02-09 2009-02-11 Wound healing agent and composition

Country Status (6)

Country Link
US (1) US7993665B2 (xx)
EP (2) EP2371377A1 (xx)
JP (1) JP5300281B2 (xx)
CA (1) CA2620029A1 (xx)
ES (1) ES2421407T3 (xx)
HK (1) HK1121383A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
WO2011157716A1 (en) 2010-06-14 2011-12-22 Gene Signal International Sa Novel peptides for wound healing
EP2395015B1 (en) * 2010-06-14 2013-03-06 Gene Signal International SA Peptides for wound healing
EP3107905B1 (en) 2014-02-20 2018-09-19 University of Notre Dame du Lac Selective matrix metalloproteinase inhibitors
WO2016044844A1 (en) 2014-09-19 2016-03-24 University Of Notre Dame Du Lac Acceleration of diabetic wound healing
CN117510592B (zh) * 2023-11-11 2024-05-31 杭州达维先医药科技有限公司 一种生物活性肽及其在制备皮肤创伤修复化妆品的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53115308A (en) * 1977-03-04 1978-10-07 Tokyo Kikai Seisakushiyo Kk Device for automatically supplying rolled paper in rotary press
DE3931852A1 (de) * 1989-09-23 1991-04-04 Erhardt & Leimer Gmbh Rollenwechsler
EP0849201B1 (de) * 1996-12-21 2002-03-06 Koenig & Bauer Aktiengesellschaft Verfahren zum Lageerfassen und Positionieren einer Vorratsbahnrolle
US20080108551A1 (en) * 2006-07-06 2008-05-08 The Secretary Of State For Defence Treatment of wounds
EP1346040A2 (en) * 2000-09-11 2003-09-24 Nuvelo, Inc. Novel nucleic acids and polypeptides
CA2461280A1 (en) * 2001-09-24 2003-04-10 Nuvelo, Inc. Novel nucleic acids and polypeptides
FR2836687A1 (fr) * 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications

Also Published As

Publication number Publication date
US7993665B2 (en) 2011-08-09
ES2421407T3 (es) 2013-09-02
EP2371377A1 (en) 2011-10-05
EP1955705B1 (en) 2013-04-17
CA2620029A1 (en) 2008-08-09
JP2008255096A (ja) 2008-10-23
US20080241210A1 (en) 2008-10-02
EP1955705A1 (en) 2008-08-13
JP5300281B2 (ja) 2013-09-25

Similar Documents

Publication Publication Date Title
MX2008009493A (es) Peptido novedoso y uso del mismo.
UA111141C2 (uk) Рекомбінантні антигени рсв
EP2532365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
RS53236B (en) BETA-AMYLOIDOSIS PEPTIDES
HK1121383A1 (en) Wound healing agent and composition
NZ623576A (en) Tfpi inhibitors and methods of use
NZ599345A (en) Immunogens from uropathogenic Escherichia Coli
WO2006135493A3 (en) A composition for wound healing and use thereof
NZ598348A (en) Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
EP2380591A3 (en) Vaccine peptide combinations against cat allergy
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
PH12015500461A1 (en) Novel il-17a binding molecules and medical uses thereof
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
PT2078038E (pt) Agentes tensioativos reconstituídos apresentando propriedades melhoradas
WO2008129422A8 (en) Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
WO2008035243A3 (en) Composition for treatment of burns and wounds
WO2010057242A3 (de) Vakzin
SE0401631D0 (sv) New Composition
WO2013088371A3 (en) Use of the mmp-12 protein in the prevention and/or treatment of dandruff conditions of the scalp
EP2572723A3 (en) Materials and methods for treating or preventing organophosphate exposure associated damage
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
CL2009000811A1 (es) Polipeptido con actividad antimicrobiana que comprende una secuencia aminoacidica de al menos un 90% de identidad con la secuencia id no:1 para producir un medicamento para tratar la meningitis; uso de dicho polipeptido para tratar la meningitis.
WO2007144492A3 (fr) Peptides a activite anti-proliferative

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170201